Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00452283 · ClinicalTrials.gov registry record
Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 23
- Enrollment target
NCT00452283 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants.
The verdict
NCT00452283 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
There is growing evidence that a cause of glaucoma is linked to circulatory problems and poor auto-regulation of blood flow to the optic nerve. Pulmonary hypertension (PH)is a disease characterized by low oxygen levels in the blood and altered blood circulation. The decrease in oxygen delivery to the optic nerve could lead to the loss of nerve fiber layer(NFL)in the retina and the resulting visual field compromise. This situation is characteristic of glaucoma. The ability to identify NFL thinning early could lead to earlier diagnosis of glaucoma and more effective treatment to limit dysfunction from visual field loss. We hypothesize that the rate of structural damage to the NFL, a feature of glaucoma, is higher in patients with PH than expected in healthy populations lacking this disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00452283
The ClinicalTrials.gov registry entry for NCT00452283 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00452283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00452283 about?
NCT00452283 is a clinical study titled "Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy". There is growing evidence that a cause of glaucoma is linked to circulatory problems and poor auto-regulation of blood flow to the optic nerve. Pulmonary hypertension (PH)is a disease characterized by low oxygen levels in the blood and altered blood circulation. The decrease in oxygen delivery to th...
What is the current status of trial NCT00452283?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2007-03. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00452283?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.